Hikari Power LTD Alpine Immune Sciences, Inc. Transaction History

Hikari Power LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 13, 2022	BUY	$6.41 - $13.89 $12,820 - $27,780	2,000 Added 19.15%	12,445 $112,000
Q3 2020 Oct 08, 2020	SELL	$7.15 - $11.5 $286,000 - $460,000	-40,000 Reduced 79.29%	10,445 $92,000
Q2 2020 Aug 13, 2020	SELL	$2.77 - $12.1 $324,486 - $1.42 Million	-117,143 Reduced 69.9%	50,445 $490,000
Q1 2020 Apr 23, 2020	SELL	$2.15 - $4.41 $38,052 - $78,052	-17,699 Reduced 9.55%	167,588 $483,000
Q4 2019 Feb 04, 2020	SELL	$2.45 - $3.87 $735 - $1,161	-300 Reduced 0.16%	185,287 $712,000
Q3 2019 Oct 31, 2019	BUY	$3.5 - $5.0 $224,784 - $321,120	64,224 Added 52.92%	185,587 $735,000
Q2 2019 Aug 08, 2019	SELL	$4.08 - $7.75 $6,564 - $12,469	-1,609 Reduced 1.31%	121,363 $511,000
Q4 2018 Jan 29, 2019	BUY	$3.68 - $6.07 $452,536 - $746,440	122,972 New	122,972 $453,000

56.2K

Ticker ALPN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,006,700
Description
Alpine Immune Sciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28...

Get notified when there are updates to the investment portfolio of Hikari Power LTD, based on Form 13F filings with the SEC.

Stay updated on Hikari Power LTD with notifications on news.